Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Sturfelt G, Jönsen A, Truedsson L, Bengtsson AA.

PLoS One. 2014 Jun 12;9(6):e99386. doi: 10.1371/journal.pone.0099386. eCollection 2014.

PMID:
24922069
[PubMed - in process]
Free PMC Article
2.

Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?

Lood C, Eriksson S, Gullstrand B, Jönsen A, Sturfelt G, Truedsson L, Bengtsson AA.

Lupus. 2012 Nov;21(13):1423-32. doi: 10.1177/0961203312457210. Epub 2012 Aug 9.

PMID:
22878256
[PubMed - indexed for MEDLINE]
3.

Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.

Peerschke EI, Yin W, Alpert DR, Roubey RA, Salmon JE, Ghebrehiwet B.

Lupus. 2009 May;18(6):530-8. doi: 10.1177/0961203308099974.

PMID:
19395455
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.

Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, Roos van Groningen M, Steup-Beekman GM, de Heer E, Bruijn JA, Bajema IM.

Arthritis Rheum. 2008 Aug;58(8):2460-9. doi: 10.1002/art.23662.

PMID:
18668574
[PubMed - indexed for MEDLINE]
Free Article
5.

Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.

Kao AH, McBurney CA, Sattar A, Lertratanakul A, Wilson NL, Rutman S, Paul B, Navratil JS, Scioscia A, Ahearn JM, Manzi S.

Transl Stroke Res. 2014 Aug;5(4):510-8. doi: 10.1007/s12975-013-0295-9. Epub 2013 Oct 27.

PMID:
24323718
[PubMed - in process]
6.

Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.

Martínez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Rueda M, Aguirre C.

Lupus. 2004;13(12):927-33.

PMID:
15645748
[PubMed - indexed for MEDLINE]
7.

Platelet C4d is highly specific for systemic lupus erythematosus.

Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, Shaw PS, Nilson AC, Dryden ER, Johnson JJ, Ahearn JM.

Arthritis Rheum. 2006 Feb;54(2):670-4. Erratum in: Arthritis Rheum. 2006 Jun;54(6):2009.

PMID:
16447243
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.

Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.

J Rheumatol. 2006 Oct;33(10):1980-6.

PMID:
17014014
[PubMed - indexed for MEDLINE]
10.

Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.

Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.

Ann Rheum Dis. 2008 Mar;67(3):395-401. Epub 2007 Jul 20.

PMID:
17644539
[PubMed - indexed for MEDLINE]
11.

Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.

Kim MK, Maeng YI, Lee SJ, Lee IH, Bae J, Kang YN, Park BT, Park KK.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):2157-67. eCollection 2013.

PMID:
24133594
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Platelet C4d is associated with acute ischemic stroke and stroke severity.

Mehta N, Uchino K, Fakhran S, Sattar MA, Branstetter BF 4th, Au K, Navratil JS, Paul B, Lee M, Gallagher KM, Manzi S, Ahearn JM, Kao AH.

Stroke. 2008 Dec;39(12):3236-41. doi: 10.1161/STROKEAHA.108.514687. Epub 2008 Oct 16.

PMID:
18927458
[PubMed - indexed for MEDLINE]
Free Article
13.

Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus.

Hein E, Nielsen LA, Nielsen CT, Munthe-Fog L, Skjoedt MO, Jacobsen S, Garred P.

Mol Immunol. 2014 Jul 25. pii: S0161-5890(14)00173-4. doi: 10.1016/j.molimm.2014.07.003. [Epub ahead of print]

PMID:
25069872
[PubMed - as supplied by publisher]
14.

Blood platelets activate the classical pathway of human complement.

Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B.

J Thromb Haemost. 2006 Sep;4(9):2035-42.

PMID:
16961611
[PubMed - indexed for MEDLINE]
15.

MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus.

Goldstein R, Moulds JM, Smith CD, Sengar DP.

J Rheumatol. 1996 Jul;23(7):1173-9.

PMID:
8823688
[PubMed - indexed for MEDLINE]
16.

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.

Kao AH, Navratil JS, Ruffing MJ, Liu CC, Hawkins D, McKinnon KM, Danchenko N, Ahearn JM, Manzi S.

Arthritis Rheum. 2010 Mar;62(3):837-44. doi: 10.1002/art.27267.

PMID:
20187154
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.

Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y.

Clin Chem. 2001 Jun;47(6):1008-15.

PMID:
11375285
[PubMed - indexed for MEDLINE]
Free Article
18.

Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.

Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.

Arthritis Rheum. 2011 Aug;63(8):2436-44. doi: 10.1002/art.30401.

PMID:
21506094
[PubMed - indexed for MEDLINE]
Free Article
19.

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.

Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, Bajema IM.

J Pathol. 2011 Dec;225(4):502-11. doi: 10.1002/path.2893. Epub 2011 Jun 20.

PMID:
21688269
[PubMed - indexed for MEDLINE]
20.

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.

Arthritis Rheum. 2009 Jan 15;61(1):29-36. doi: 10.1002/art.24232.

PMID:
19116963
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk